{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:05:10Z","timestamp":1758845110893,"version":"3.44.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100016238","name":"Alkoholitutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007797","name":"Helsingin Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010114","name":"Yrj\u00f6 Jahnssonin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010114","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007083","name":"Orionin Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007083","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.pbb.2020.172852","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T20:16:43Z","timestamp":1579033003000},"page":"172852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Behavioral responses of mGluR3-KO mice to the lipopolysaccharide-induced innate inflammatory reaction"],"prefix":"10.1016","volume":"190","author":[{"given":"Mira","family":"Lainiola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anni-Maija","family":"Linden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teemu","family":"Aitta-aho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2020.172852_bb0005","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/glia.23343","article-title":"Genetic deletion of xCT attenuates peripheral and central inflammation and mitigates LPS-induced sickness and depressive-like behavior in mice","volume":"66","author":"Albertini","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.pbb.2020.172852_bb0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-0173(98)00050-2","article-title":"Metabotropic glutamate receptors: electrophysiological properties and role in plasticity","volume":"29","author":"Anwyl","year":"1999","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.pbb.2020.172852_bb0015","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.neuroscience.2004.10.024","article-title":"Activation of metabotropic glutamate receptor 3 enhances interleukin (IL)-1beta-stimulated release of IL-6 in cultured human astrocytes","volume":"130","author":"Aronica","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2020.172852_bb0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuroscience.2011.12.044","article-title":"Opposite regulation of metabotropic glutamate receptor 3 and metabotropic glutamate receptor 5 by inflammatory stimuli in cultured microglia and astrocytes","volume":"205","author":"Berger","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2020.172852_bb0025","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/271359","article-title":"Systemic immune activation leads to neuroinflammation and sickness behavior in mice","volume":"2013","author":"Biesmans","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.pbb.2020.172852_bb0030","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neuropharm.2016.04.044","article-title":"The impact of metabotropic glutamate receptors into active neurodegenerative processes: a \u201cdark side\u201d in the development of new symptomatic treatments for neurologic and psychiatric disorders","volume":"115","author":"Bruno","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2020.172852_bb0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coph.2018.02.001","article-title":"mGlu receptors as potential targets for novel antidepressants","volume":"38","author":"Chaki","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.pbb.2020.172852_bb0040","doi-asserted-by":"crossref","first-page":"8297","DOI":"10.1523\/JNEUROSCI.1889-07.2007","article-title":"The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration\/neuroprotection","volume":"27","author":"Corti","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2020.172852_bb0045","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bbi.2016.02.001","article-title":"Inhibiting neuroinflammation: the role of therapeutic potential of GABA in neuro-immune interactions","volume":"54","author":"Crowley","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pbb.2020.172852_bb0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pbb.2020.172852_bb0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuropharm.2014.08.010","article-title":"The role of group II metabotropic glutamate receptors in cognition and anxiety: comparative studies in GRM2(\u2212\/\u2212), GRM3(\u2212\/\u2212) and GRM2\/3(\u2212\/\u2212) knockout mice","volume":"89","author":"De Filippis","year":"2015","journal-title":"Neuropharmacology"},{"issue":"Suppl. 2","key":"10.1016\/j.pbb.2020.172852_bb0060","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/jnc.13607","article-title":"Neuroinflammation: the devil is in the details","volume":"139","author":"DiSabato","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2020.172852_bb0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cnr.2006.04.002","article-title":"Effects of cytokines and infections on brain neurochemistry","volume":"6","author":"Dunn","year":"2006","journal-title":"Clin. Neurosci. Res."},{"key":"10.1016\/j.pbb.2020.172852_bb0070","doi-asserted-by":"crossref","first-page":"17799","DOI":"10.1038\/srep17799","article-title":"Xanthurenic acid activates mGlu2\/3 metabotropic glutamate receptors and is a potential trait marker for schizophrenia","volume":"5","author":"Fazio","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pbb.2020.172852_bb0075","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fphar.2017.00214","article-title":"Vasorelaxing action of the kynurenine metabolite, xanthurenic acid: the missing link in endotoxin-induced hypotension?","volume":"8","author":"Fazio","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pbb.2020.172852_bb0080","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.neuropharm.2016.06.020","article-title":"Cinnabarinic acid and xanthurenic acid: two kynurenine metabolites that interact with metabotropic glutamate receptors","volume":"112","author":"Fazio","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2020.172852_bb0085","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.coph.2018.01.010","article-title":"Targeting metabotropic glutamate receptors for the treatment of neuroinflammation","volume":"38","author":"Fazio","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.pbb.2020.172852_bb0090","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/npp.2016.143","article-title":"Inflammation effects on motivation and motor activity: role of dopamine","volume":"42","author":"Felger","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2020.172852_bb0095","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.psyneuen.2007.03.005","article-title":"Lipopolysaccharide induces delayed FosB\/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior","volume":"32","author":"Frenois","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pbb.2020.172852_bb0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1756-6606-7-31","article-title":"Comprehensive behavioral study of mGluR3 knockout mice: implication in schizophrenia related endophenotypes","volume":"7","author":"Fujioka","year":"2014","journal-title":"Mol. Brain"},{"key":"10.1016\/j.pbb.2020.172852_bb0105","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2174\/18715273113129990079","article-title":"mGlu2\/3 agonist-induced hyperthermia: an in vivo assay for detection of mGlu2\/3 receptor antagonism and its relation to antidepressant-like efficacy in mice","volume":"12","author":"Gleason","year":"2013","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.pbb.2020.172852_bb0110","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0269881108089818","article-title":"The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia","volume":"22","author":"Harrison","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pbb.2020.172852_bb0115","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/s41386-019-0380-1","article-title":"Group II metabotropic glutamate receptor blockade promotes stress resilience in mice","volume":"44","author":"Highland","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2020.172852_bb0120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12974-015-0332-6","article-title":"Systemic inflammation and microglial activation: systematic review of animal experiments","volume":"12","author":"Hoogland","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.pbb.2020.172852_bb0125","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbr.2014.03.008","article-title":"mGluR3 knockout mice show a working memory defect and an enhanced response to MK-801 in the T- and Y-maze cognitive tests","volume":"266","author":"Lainiola","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2020.172852_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024159","article-title":"Removal of GABA(A) receptor gamma2 subunits from parvalbumin neurons causes wide-ranging behavioral alterations","volume":"6","author":"Leppa","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2020.172852_bb0135","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00213-004-2098-x","article-title":"Anxiolytic-like activity of the mGLU2\/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice","volume":"179","author":"Linden","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2020.172852_bb0140","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clim.2015.05.016","article-title":"Ligation of metabotropic glutamate receptor 3 (Grm3) ameliorates lupus-like disease by reducing B cells","volume":"160","author":"Ma","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.pbb.2020.172852_bb0145","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice","volume":"14","author":"O\u2019Connor","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pbb.2020.172852_bb0150","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1113\/jphysiol.2003.048140","volume":"551","author":"Oka","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.pbb.2020.172852_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020719","article-title":"Prolonged depression-like behavior caused by immune challenge: influence of mouse strain and social environment","volume":"6","author":"Painsipp","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2020.172852_bb0160","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1742-2094-8-179","article-title":"Insulin-like growth factor-I peptides act centrally to decrease depression-like behavior of mice treated intraperitoneally with lipopolysaccharide","volume":"8","author":"Park","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.pbb.2020.172852_bb0165","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1460-9568.2010.07485.x","article-title":"Excessive novelty-induced c-Fos expression and altered neurogenesis in the hippocampus of GluA1 knockout mice","volume":"33","author":"Procaccini","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pbb.2020.172852_bb0170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coph.2018.02.003","article-title":"The therapeutic potential of metabotropic glutamate receptor modulation for schizophrenia","volume":"38","author":"Stansley","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.pbb.2020.172852_bb0175","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0165-5728(00)00269-1","article-title":"Expression of metabotropic glutamate receptors in murine thymocytes and thymic stromal cells","volume":"109","author":"Storto","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.pbb.2020.172852_bb0180","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/npp.2013.71","article-title":"NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL\/6J mice","volume":"38","author":"Walker","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2020.172852_bb0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbi.2005.08.007","article-title":"Metabotropic glutamate receptors mediate lipopolysaccharide-induced fever and sickness behavior","volume":"20","author":"Weiland","year":"2006","journal-title":"Brain Behav. Immun."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305719305349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305719305349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:37:04Z","timestamp":1758775024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305719305349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":37,"alternative-id":["S0091305719305349"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2020.172852","relation":{},"ISSN":["0091-3057"],"issn-type":[{"type":"print","value":"0091-3057"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behavioral responses of mGluR3-KO mice to the lipopolysaccharide-induced innate inflammatory reaction","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2020.172852","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172852"}}